Root-Securing and Brain-Fortifying Liquid Upregulates Caveolin-1 in Cell Model with Alzheimer’s Disease through Inhibiting Tau Phosphorylation

Root-Securing and Brain-Fortifying Liquid Upregulates Caveolin-1 in Cell Model with Alzheimer’s Disease through Inhibiting Tau Phosphorylation

In order to explore the effect of root-securing and brain-fortifying Liquid- (RSBFL-) mediated caveolin-1 (CAV-1) on phosphorylation of Tau protein and to uncover underlying mechanisms of RSBFL for the prevention and treatment of Alzheimer’s disease (AD), hippocampal neurons isolated from neonatal S...

Full description

Saved in:

Bibliographic Details
Main Authors:	Depei Yuan, Chuhua Zeng, Qianfeng Chen, Fengjie Wang, Lin Yuan, Yaoqian Zhu, Ziyang Shu, Ning Chen
Format:	Article
Language:	English
Published:	Wiley 2017-01-01
Series:	Neurology Research International
Online Access:	http://dx.doi.org/10.1155/2017/6248351
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Retinal tau phosphorylation in Alzheimer's disease: A mass spectrometry study
by: Jessica Santiago, et al.
Published: (2025-10-01)

Synaptic loss pattern is constrained by brain connectome and modulated by phosphorylated tau in Alzheimer’s disease
by: Ying Luan, et al.
Published: (2025-07-01)

Isoforms of Phosphorylated Tau as Potential Biomarkers for Alzheimer’s Disease: The Contribution of Mass Spectrometry-Based Proteomics
by: Marco Agostini, et al.
Published: (2025-06-01)

Syk inhibitors reduce tau protein phosphorylation and oligomerization
by: Tomohisa Yamaguchi, et al.
Published: (2024-10-01)

Parvalbumin interneurons in the hippocampal formation of individuals with Alzheimer’s disease: a neuropathological study of abnormal phosphorylated tau in neurons
by: Paula Merino-Serrais, et al.
Published: (2025-04-01)

The Role of α-Synuclein and LRRK2 in Tau Phosphorylation
by: Fumitaka Kawakami, et al.
Published: (2015-01-01)

Effect of calcium ions on the aggregation of highly phosphorylated tau
by: Toru Tanaka, et al.
Published: (2024-12-01)

The critical roles of caveolin-1 in lung diseases
by: Jiarun Fan, et al.
Published: (2024-09-01)

Electrochemical modulation of tau protein phosphorylation levels with biomimetic polyaniline membranes
by: Shang-Chi Chien, et al.
Published: (2025-06-01)

Upregulated astrocyte HDAC7 induces Alzheimer-like tau pathologies via deacetylating transcription factor-EB and inhibiting lysosome biogenesis
by: Jinwang Ye, et al.
Published: (2025-01-01)

The excitotoxin quinolinic acid induces tau phosphorylation in human neurons.
by: Abdur Rahman, et al.
Published: (2009-07-01)

Stromal Caveolin-1 and Caveolin-2 Expression in Primary Tumors and Lymph Node Metastases
by: Wladimir Gerstenberger, et al.
Published: (2018-01-01)

A novel miR-4536-3p inhibition ameliorates Alzheimer’s disease by reducing Aβ accumulation and tau phosphorylation
by: Jiyun Choi, et al.
Published: (2025-08-01)

RA-PR058, a novel ramalin derivative, reduces BACE1 expression and phosphorylation of tau in Alzheimer’s disease mouse models
by: Yongeun Cho, et al.
Published: (2025-12-01)

Galectin-3 Secreted by Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells Reduces Aberrant Tau Phosphorylation in an Alzheimer Disease Model
by: Hoon Lim, et al.
Published: (2020-01-01)

Identification of the sites of tau hyperphosphorylation and activation of tau kinases in synucleinopathies and Alzheimer's diseases.
by: Valeriy Duka, et al.
Published: (2013-01-01)

Caveolae and caveolins role in health and disease
by: R. I. Voroblev, et al.
Published: (2008-12-01)

Caveolin and oxidative stress in cardiac pathology
by: Lauren Zadorozny, et al.
Published: (2025-02-01)

Vascular β-amyloid potentially colocalises with phosphorylated tau in cerebral amyloid angiopathy
by: Li-Kai Tsai, et al.

Palmitoyl-L-carnitine induces tau phosphorylation and mitochondrial dysfunction in neuronal cells.
by: Gwangho Yoon, et al.
Published: (2024-01-01)

Cross‐sectional study of plasma phosphorylated tau 217 in persons without dementia
by: Toni T. Saari, et al.
Published: (2025-04-01)

18F‐AV‐1451 and CSF T‐tau and P‐tau as biomarkers in Alzheimer's disease
by: Niklas Mattsson, et al.
Published: (2017-07-01)

Retraction: Identification of the Sites of Tau Hyperphosphorylation and Activation of Tau Kinases in Synucleinopathies and Alzheimer’s Diseases
Published: (2025-01-01)

The Role and Pathogenesis of Tau Protein in Alzheimer’s Disease
by: Xiaoyue Hong, et al.
Published: (2025-06-01)

Tau‐targeting nanoparticles for treatment of Alzheimer's disease
by: Shreya Pawar, et al.
Published: (2025-04-01)

Plasma phosphorylated tau 217 and amyloid‑β 42/40 for amyloid risk in subgroups
by: Heekyoung Kang, et al.
Published: (2025-08-01)

GRAMD1B is a regulator of lipid homeostasis, autophagic flux and phosphorylated tau
by: Diana Acosta Ingram, et al.
Published: (2025-04-01)

Clinical and demographic factors modify the association between plasma phosphorylated tau‐181 and cognition
by: Corey J. Bolton, et al.
Published: (2024-10-01)

Phosphorylated TDP-43 and tau deposition around the tip of deep brain stimulation leads
by: Goichi Beck, et al.
Published: (2025-06-01)

Phosphorylated tau 181 and 217 are elevated in serum and muscle of patients with amyotrophic lateral sclerosis
by: Samir Abu-Rumeileh, et al.
Published: (2025-03-01)

Caveolin-1: an ambiguous entity in breast cancer
by: Naveen Chintalaramulu, et al.
Published: (2025-04-01)

WCN24-2499 CAVEOLIN-1 AND CAVEOLIN-2 AS POTENTIAL URINARY EARLY BIOMARKERS OF RENAL INJURY IN ACUTE CHOLESTASIS IN RATS
by: Anabel Brandoni, et al.
Published: (2024-04-01)

Blood phosphorylated Tau181 reliably differentiates amyloid‐positive from amyloid‐negative subjects in the Alzheimer's disease continuum: A systematic review and meta‐analysis
by: Annibale Antonioni, et al.
Published: (2025-01-01)

The impact of pimavanserin on psychotic phenotypes and tau phosphorylation in the P301L/COMT– and rTg(P301L)4510 mouse models of Alzheimer's disease
by: Heidy Jimenez, et al.
Published: (2022-01-01)

Neuron-targeted caveolin-1 overexpression attenuates cognitive loss and pathological transcriptome changes in symptomatic Alzheimer’s disease models
by: Dongsheng Wang, et al.
Published: (2025-05-01)

Axonal tau reduction ameliorates tau and amyloid pathology in a mouse model of Alzheimer’s disease
by: Abdolhossein Zare, et al.
Published: (2025-07-01)

Hyperphosphorylated tau-based Alzheimer’s Disease drug discovery: Identification of inhibitors of tau aggregation and cytotoxicity
by: Hsiao-Tien Hagar, et al.
Published: (2025-06-01)

Molecular Insights into Tau Pathology and its Therapeutic Strategies in Alzheimer's Disease
by: Futao Zhou, et al.
Published: (2024-10-01)

Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer’s continuum when only subtle changes in Aβ pathology are detected
by: Marc Suárez‐Calvet, et al.
Published: (2020-11-01)

Identification of Stk25 as a genetic modifier of Tau phosphorylation in Dab1-mutant mice.
by: Tohru Matsuki, et al.
Published: (2012-01-01)